Home›Legal›Ipamorelin in Texas
Ipamorelin in Texas: Legal Status & Provider Guide (2026)
Quick Answer
Ipamorelin is a prescription substance in the United States. Ipamorelin is an unapproved research peptide with no FDA bulk compounding authorization. While it has been offered by compounding pharmacies under various interpretations, federal compliance risk is elevated. Patients should verify current regulatory standing with their provider. In Texas, compounding is governed by the Texas State Board of Pharmacy (TSBP). In Texas, physician assistants and nurse practitioners with prescriptive authority can prescribe compounded medications including peptides. Prescribers must hold an active Texas license. Telemedicine prescribing of controlled substances and certain compounded medications is permitted under Texas Medical Board rules with specific conditions.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on the FDA 503A or 503B bulk substances lists. Ipamorelin's compounding status is contested — it was removed from the 503A consideration list and faces similar restrictions to other unapproved peptides.
Compounding Pharmacy Rules (Federal)
Ipamorelin is not on the FDA-approved 503A or 503B bulk substances lists. Some compounding pharmacies have offered it historically, but FDA guidance suggests significant legal risk. Its status is often treated similarly to CJC-1295 and other non-listed peptides. Legal compounding under federal oversight is uncertain.
Also Known As
NNC 26-0161
Primary Research Areas
- Growth hormone stimulation
- Anti-aging
- Body composition
- Recovery
Texas Pharmacy Board & Compounding Rules
Regulator
Compounding Overview
Texas is home to one of the largest compounding pharmacy industries in the country, with detailed rules set by the Texas State Board of Pharmacy (TSBP). Texas 503A pharmacies may compound non-FDA-approved peptides under certain conditions, though federal FDA guidance takes precedence for pharmacies participating in the national regulatory framework. Texas-specific rules address sterile compounding standards, USP 797 compliance, and registration requirements for non-resident pharmacies shipping into the state.
Notable Rules
- Texas TSBP requires sterile compounding facilities to comply with USP 797 standards.
- Non-resident (out-of-state) pharmacies shipping compounded products into Texas must be registered with the TSBP.
- Texas prohibits the sale of prescription-only compounded products without a valid prescription.
- The Texas Medical Board regulates prescribing standards for telemedicine encounters including peptide programs.
Prescribing Requirements in Texas
In Texas, physician assistants and nurse practitioners with prescriptive authority can prescribe compounded medications including peptides. Prescribers must hold an active Texas license. Telemedicine prescribing of controlled substances and certain compounded medications is permitted under Texas Medical Board rules with specific conditions.
About Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHSR agonist) and a pentapeptide. It stimulates growth hormone release with reportedly high selectivity — less stimulation of cortisol and prolactin than earlier GHRPs. Most evidence comes from animal studies.
For more research information, mechanism of action, and provider availability, see the Ipamorelin research profile on PeptideBase.
Frequently Asked Questions
- Is ipamorelin legally available from compounding pharmacies?
- Ipamorelin is not on the FDA bulk substances lists for 503A or 503B compounding. Some pharmacies have offered it, but federal compliance is uncertain. The regulatory environment has tightened since 2021. Patients should ask their provider for explicit documentation of the legal basis.
Ipamorelin Providers in Texas
No providers currently listed in Texas for Ipamorelin. Browse the full directory to find providers offering Ipamorelin.
Browse all Ipamorelin providers →Ipamorelin Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare Ipamorelin legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .